Loading organizations...
Loading organizations...
Developer of externally sourced cancer therapeutics with a unique model.
Cullinan Therapeutics has raised $379.7M across 3 funding rounds.
Cullinan Therapeutics has raised $379.7M in total across 3 funding rounds.
Cullinan Therapeutics has raised $379.7M in total across 3 funding rounds.
Cullinan Therapeutics's investors include Foresite Capital, Baupost Group, Boxer Capital, BVF Partners, Cowen Healthcare Investments, Eventide Asset Management, F2 Ventures, Leerink Partners, Logos Capital, MPM Capital, Nextech Invest, OrbiMed.
Cullinan Therapeutics has raised $379.7M across 3 funding rounds. Most recently, it raised $131.2M Series C in December 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 17, 2020 | $131.2M Series C | Foresite Capital | Baupost Group, Boxer Capital, BVF Partners, Cowen Healthcare Investments, Eventide Asset Management, F2 Ventures, Leerink Partners, Logos Capital, MPM Capital, Nextech Invest, OrbiMed, Rock Springs Capital, Schooner Capital, Venrock |
| Jun 4, 2020 | $98.5M Series B | F2 Ventures, Jon Wigginton, MD | |
| Oct 3, 2017 | $150.0M Series A | F2 Ventures, UBS |